Back to home
DEALS & FUNDINGMarch 15, 2026·5 min read
TerraPower Isotopes Invests $450M in Actinium-225 Production
The Gates-backed nuclear isotope venture plans a dedicated Ac-225 facility, addressing the critical supply bottleneck that has constrained next-generation alpha-emitting radiopharmaceutical development.
The full analysis is published in the weekly biotech.today newsletter — subscribe for free to get the next issue in your inbox.